Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€505.00

€505.00

-1.940%
-10.0
-1.940%
€600.54
 
22.08.24 / Stuttgart Stock Exchange WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Chemed

sharewise wants to provide you with the best news and tools for Chemed, so we directly link to the best financial data sources.

News

Chemed Corporation Declares Quarterly Dividend of 50 Cents:
Chemed Corporation Declares Quarterly Dividend of 50 Cents


Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on August 30, 2024, to

Chemed Reports Second-Quarter 2024 Results:
Chemed Reports Second-Quarter 2024 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25:
Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, following the close of trading on the

Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference:
Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference


Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. (ET) at

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend:
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting.



Stockholders ratified the continuation of

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024:
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the

Chemed Reports First-Quarter 2024 Results:
Chemed Reports First-Quarter 2024 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama:
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama


VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an

Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25:
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the

VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama:
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama


VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and

Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference:
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024, at approximately 12:00

Chemed Reports Fourth-Quarter 2023 Results:
Chemed Reports Fourth-Quarter 2023 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest